Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 9,496Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Zenara Pharma

02 1Accord healthcare

03 6Ajanta Pharma Limited

04 6Alembic Pharmaceuticals Limited

05 6Alkem Laboratories

06 6Amneal Pharmaceuticals

07 5Apotex Inc

08 6Aurobindo Pharma Limited

09 6Chartwell Pharmaceuticals llc

10 14H. Lundbeck AS

11 6Hetero Drugs

12 6Intas Pharmaceuticals

13 6Lupin Ltd

14 6MSN Laboratories

15 6Otsuka Chemical Co Ltd

16 6Otsuka Holdings

17 11Otsuka Pharmaceutical

18 6Prinston

19 6Sandoz B2B

20 6Teva Pharmaceutical Industries

21 6Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank